title: Adjuvant chemotherapy of stage-ii nonseminomatous testicular cancer.
abstract: 85 patients with resected stage II non-seminomatous testicular cancer were treated with adjuvant cisplatin-based chemotherapy. Only one patient developed a relapse 14 months after discontinuation of adjuvant chemotherapy, which was successfully treated with salvage chemotherapy. One patient developed a contralateral testicular tumor 6 years after primary therapy. After a median observation time of 6 years (range 2 months to 13 years) 84 patients are alive without evidence of testicular cancer; one died from an unrelated cause. In conclusion, adjuvant cisplatin-based chemotherapy for resected stage Il nonseminomatous testicular cancer almost always prevents relapse.
authors: ONKOL KLIN BAD TRISSL,DEPT INTERNAL MED,D-83080 OBERAUDORF,GERMANY.
authors: A
authors: A
authors: Gerl
authors: C
authors: C
authors: Clemm
authors: P
authors: P
authors: Kohl
authors: A
authors: A
authors: Schalhorn
authors: W
authors: W
authors: Wilmanns